Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

Giant-Cell Arteritis Market: What is the Projected CAGR for 2024-2033?

The giant-cell arteritis market has shown steady growth in recent years. It is expected to rise from $1.02 billion in 2023 to $1.07 billion in 2024, with a CAGR of 4.9%. Factors contributing to this growth include epidemiological studies, genetic research, increased use of biologics, enhanced diagnostic methods, and the development of targeted therapies and biologics.

The giant-cell arteritis market is expected to experience strong growth, projected to reach $1.30 billion in 2028 with a CAGR of 5.1%. This growth is driven by increasing diagnosis rates, an aging population, rising healthcare expenditure, patient advocacy, and geographic expansion. Major trends include advancements in biomarker identification, development of therapies targeting specific molecular pathways, adoption of advanced imaging techniques, drug delivery innovations, and the use of AI algorithms for predictive analytics.

What Are the Primary Drivers Supporting the Growth of the Giant-Cell Arteritis Market?

The giant-cell arteritis market is expected to grow due to the increasing emphasis on personalized medicine. This approach tailors medical treatment to individual characteristics, such as genetics, lifestyle, and environment. The rise of personalized medicine is driven by advancements in genomics, biotechnology, and data analytics, enabling targeted therapies that enhance treatment efficacy and minimize adverse effects. Personalized medicine can support giant-cell arteritis (GCA) through targeted therapies based on individual patient factors, such as genetic predispositions, immune profiles, and disease manifestations. For instance, in February 2024, the Personalized Medicine Coalition reported that personalized medicines constituted over one-third of new drug approvals by the U.S. Food and Drug Administration for the fourth consecutive year in 2023. That year, the FDA approved 16 new personalized treatments for rare diseases, a significant rise from six in 2022. Additionally, the 2023 approvals included seven cancer medications and three for various other conditions. Consequently, the growing focus on personalized medicine is driving the giant-cell arteritis market.

Claim Your Free Sample of the Global Giant-Cell Arteritis Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=17162&type=smp

What Are the Core Segments of the Giant-Cell Arteritis Market?

The giant-cell arteritis market covered in this report is segmented –

1) By Therapeutics: Prednisone, Methotrexate, Tocilizumab, Aspirin
2) By Mechanism Of Action: Corticosteroids, Immunosuppressive Agents, Anticoagulants, Other Mechanisms Of Action
3) By Route Of Administration: Oral, Intravenous, Subcutaneous, Other Routes Of Administration

What Trends Are Paving the Way for Change in the Giant-Cell Arteritis Market?

Companies are introducing biosimilars to address unmet medical needs. In April 2024, Fresenius SE & Co. KGaA from Germany launched Tocilizumab-aazg in the US for chronic autoimmune diseases.

Order Now for Fast Delivery of Your Giant-Cell Arteritis Market Report!

https://www.thebusinessresearchcompany.com/report/giant-cell-arteritis-global-market-report

Which Regions Are Leading the Charge in Giant-Cell Arteritis Market Development?

North America was the largest region in the giant-cell arteritis market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the giant-cell arteritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Giant-Cell Arteritis Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the giant-cell arteritis market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Giant-Cell Arteritis Market Include

1. Giant-Cell Arteritis Market Executive Summary
2. Giant-Cell Arteritis Market Segments
3. Giant-Cell Arteritis Market Size And Template Market Growth Rate
4.  Key Giant-Cell Arteritis Market Trends
5. Major Giant-Cell Arteritis Market Drivers
……
25. Key Mergers And Acquisitions In The Giant-Cell Arteritis Market
26. Top Giant-Cell Arteritis Companies
27. Giant-Cell Arteritis Market Opportunities And Strategies
28. Giant-Cell Arteritis Market, Conclusions And Recommendations
29. Appendix

Discover Related Reports by The Business Research Company:

Cell Culture Consumables And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cell-culture-consumables-and-equipment-global-market-report

Automotive Smart Display Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/automotive-smart-display-global-market-report

Induced Pluripotent Stem (iPSC) Cell Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/induced-pluripotent-stem-cell-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: